AOSIDA Trademark

Trademark Overview


On Tuesday, August 17, 2010, a trademark application was filed for AOSIDA with the United States Patent and Trademark Office. The USPTO has given the AOSIDA trademark a serial number of 79087136. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, August 18, 2020. This trademark is owned by Hebei Changshan Biochemical Pharmaceutical Co., LTD. The AOSIDA trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for the treatment of cardiovascular and cerebrovascular diseases, thrombus; gelatin (e) for medical purposes, namely, gelatin capsules sold empty for pharmaceuticals; raw material medicine, namely, heparin sodium; biomedicine, namely, heparin sodium; dietetic food adapted for medical purposes; dietetic substances adapted for medical purposes, namely, beverages, sugars; nutritive substances for microorganisms for medical purposes; injections, namely, heparin sodium; tablets, namely, drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, for the treatment of cardiovascular and cerebrovascular diseases, thrombus
aosida

General Information


Serial Number79087136
Word MarkAOSIDA
Filing DateTuesday, August 17, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, August 18, 2020
Registration Number4030492
Registration DateTuesday, September 27, 2011
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 12, 2011

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of three Chinese characters under the corresponding Pinyin "AOSIDA".
Goods and ServicesChemico-pharmaceutical preparations for the treatment of cardiovascular and cerebrovascular diseases, thrombus; gelatin (e) for medical purposes, namely, gelatin capsules sold empty for pharmaceuticals; raw material medicine, namely, heparin sodium; biomedicine, namely, heparin sodium; dietetic food adapted for medical purposes; dietetic substances adapted for medical purposes, namely, beverages, sugars; nutritive substances for microorganisms for medical purposes; injections, namely, heparin sodium; tablets, namely, drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drugs for medical purposes, namely, for the treatment of cardiovascular and cerebrovascular diseases, thrombus
Transliteration StatementThe non-Latin characters in the mark transliterate to "AOSIDA", and this has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHebei Changshan Biochemical Pharmaceutical Co., LTD
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHebei Province
CN

Party NameHebei Changshan Biochemical Pharmaceutical Co., LTD
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHebei Province
CN

Party NameHebei Changshan Biochemical Pharmaceutical Co., LTD
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHebei Province
CN

Trademark Events


Event DateEvent Description
Sunday, April 11, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, April 11, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, February 15, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, January 17, 2019GENERIC MADRID TRANSACTION SENT TO IB
Thursday, January 17, 2019GENERIC MADRID TRANSACTION CREATED
Friday, January 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 4, 2018CANCELLED SECTION 71
Saturday, May 19, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 2, 2012FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 2, 2012FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2011REGISTERED-PRINCIPAL REGISTER
Sunday, September 4, 2011NOTIFICATION PROCESSED BY IB
Tuesday, July 12, 2011PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 22, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 22, 2011NOTICE OF PUBLICATION
Wednesday, June 8, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, May 26, 2011ASSIGNED TO LIE
Friday, May 13, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 12, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 12, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 12, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 27, 2011NON-FINAL ACTION MAILED
Tuesday, April 26, 2011NON-FINAL ACTION WRITTEN
Friday, March 25, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 1, 2011REFUSAL PROCESSED BY IB
Wednesday, December 15, 2010NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, December 15, 2010REFUSAL PROCESSED BY MPU
Wednesday, December 15, 2010NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 14, 2010NON-FINAL ACTION WRITTEN
Thursday, December 2, 2010ASSIGNED TO EXAMINER
Tuesday, October 19, 2010APPLICATION FILING RECEIPT MAILED
Friday, October 15, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 14, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB